TechCon SoCal 2026

Engineering the Next Era of Medicine: AI, mRNA, Gene Therapy, and Advanced Biologics

May
22
2026

Date: May 22, 2026

Location: San Diego, CA

On May 22, Tali Tuchin moderated a panel titled "Engineering the Next Era of Medicine: AI, mRNA, Gene Therapy, and Advanced Biologics" at TechCon SoCal.

The next wave of life sciences innovation was shaped by the convergence of AI, advanced therapies, precision oncology, mRNA platforms, gene therapy, and scalable biomanufacturing. The panel explored how breakthrough science moved from the lab into commercial reality, and what it took to navigate clinical validation, manufacturing, regulation, capital formation, and market adoption. The conversation connected scientific ambition with practical execution—highlighting how founders, investors, and industry leaders were redefining what medicine could become over the next decade.

Featured panelists included:

  • Kate Broderick, Chief Scientific and Innovation Officer, Artis BioSolutions
  • Paul Grint, Executive Chairman, CRISPRQC
  • Magda Marquet, Co-Founder, Acurion
  • Jan Karlseder, Vice President, Chief Science Officer, Salk Institute


 

Professionals

  • Tali M. Tuchin

    • Related Industries

  • Life Sciences

    • Speakers

    Tali M. Tuchin

    Tali M. Tuchin

    Moderator

    Tali M. Tuchin is a Mintz Member who handles complex business and technology transactions, including patent licenses and assignments, research and development agreements, and collaboration agreements. Her clients range from start-ups to large public companies in a variety of sectors, including biotechnology, pharmaceuticals, diagnostics, medical devices, health care, energy, and technology.